Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Taysha Gene Therapies Inc (NQ: TSHA ) 2.300 +0.030 (+1.32%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Taysha Gene Therapies Inc < Previous 1 2 3 4 5 6 7 Next > Earnings Scheduled For March 31, 2022 March 31, 2022 Companies Reporting Before The Bell • Trevena (NASDAQ:TRVN) is likely to report earnings for its fourth quarter. Via Benzinga Taysha Gene Therapies's Earnings Outlook March 30, 2022 Taysha Gene Therapies (NASDAQ:TSHA) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that... Via Benzinga Taysha Reports Efficacy, Safety Data From High Dose Cohort For Neurological Disorder Gene Therapy Trial January 31, 2022 Taysha Gene Therapies Inc (NASDAQ: TSHA) has Via Benzinga Taysha Gene Plans Protocol Amendment After Patient Death In Gene Therapy Trial January 27, 2022 Taysha Gene Therapies Inc (NASDAQ: TSHA) reported Via Benzinga Analyst Ratings For Taysha Gene Therapies August 18, 2021 Taysha Gene Therapies (NASDAQ:TSHA) has observed the following analyst rat... Via Benzinga The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict March 30, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More March 27, 2022 Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets. Via Benzinga The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline August 18, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Exposures Product Safety Taysha Gene Therapies Earnings Conference Call Is Coming Up, Here's What You Need To Know March 25, 2022 Taysha Gene Therapies (NASDAQ:TSHA) will host a conference call at 08:00 AM ET on March 31, 2022, to discuss Q4 2021 earnings results. How to Attend Taysha Gene Therapies (TSHA)... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2022 March 09, 2022 Upgrades Roth Capital upgraded the previous rating for Hudson Technologies Inc (NASDAQ:HDSN) from Neutral to Buy. For the fourth quarter, Hudson Technologies had an EPS of $0.13,... Via Benzinga Two Insider Moonshots Rising on Sudden Buying February 10, 2022 Biotech insiders are among the most important investors to pay close attention to. Here are two that show good signs for the future. Via InvestorPlace Stocks That Hit 52-Week Lows On Tuesday March 15, 2022 During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by... Via Benzinga Stocks That Hit 52-Week Lows On Monday March 14, 2022 On Monday, 671 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows: Alibaba Group Holding (NYSE:BABA) was the largest firm by... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday March 08, 2022 Tuesday's session saw 729 companies set new 52-week lows. Areas of Interest About Today's 52-Week Lows: Amazon.com (NASDAQ:AMZN) was the largest firm on a... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022 March 01, 2022 Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ:RVMD) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71,... Via Benzinga Executives Buy Around $62M Of 3 Stocks February 07, 2022 The Nasdaq index jumped more than 200 points on Friday after Amazon.com, Inc. (NASDAQ: AMZN) reported better-than-expected earnings for its fourth quarter. Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session January 20, 2022 Gainers TCR2 Therapeutics (NASDAQ:TCRR) s... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday February 22, 2022 During Tuesday's trading, 505 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The company with the largest market cap to... Via Benzinga The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus December 26, 2021 Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts, and COVID-19 treatment and vaccine developments dictating sentiment. Here are the key... Via Talk Markets Stocks That Hit 52-Week Lows On Wednesday January 19, 2022 During Wednesday's morning trading, 400 companies set new 52-week lows. 52-Week Low Highlights: Intuitive Surgical (NASDAQ:ISRG) was the largest company by... Via Benzinga Stocks That Hit 52-Week Lows On Thursday January 06, 2022 On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new 52-week low this... Via Benzinga Stocks Hitting New 52-Week Lows Today January 03, 2022 On Monday morning, 60 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows And Highs: Ginkgo Bioworks Holdings (NYSE:DNA) was... Via Benzinga The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year December 26, 2021 Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts and COVID-19 treatment and vaccine developments dictating... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2021 December 16, 2021 Upgrades According to B of A Securities, the prior rating for Generac Holdings Inc (NYSE: Via Benzinga The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré December 07, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Acadia Announces Positive Phase 3 Data For Trofinetide In Rett Syndrome... Via Benzinga Taysha Gene's Epilepsy Candidate Shows Encouraging Action In Preclinical Studies December 07, 2021 Taysha Gene Therapies Inc (NASDAQ: TSHA) announced a late-breaking abstract and poster presentation on preclinical data for TSHA-105 for SLC13A5-related epilepsy.... Via Benzinga Taysha Gene Therapies, Inc. (TSHA) Q3 2021 Earnings Call Transcript November 11, 2021 TSHA earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Taysha's Rare Epilepsy Gene Therapy Receives European Orphan Drug Tag August 25, 2021 The European Commission has granted Orphan Drug designation to Taysha Gene Therapies Inc's (NASDAQ: TSHA) TSHA-105, AAV9-based gene therapy for SLC13A5-... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session August 17, 2021 Gainers Aerpio Pharmaceuticals (NASDAQ:ARPO) stock increased by 25.72% to $2.59 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday August 17, 2021 Tuesday morning, 282 companies set new 52-week lows. Key Facts: Alibaba Group Holding (NYSE:BABA) was the biggest company by market cap to set a new 52-week low.... Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.